Lipopolysaccharide-pretreated plasmacytoid dendritic cells ameliorate experimental chronic kidney disease

Kidney International

Volumn 81, Issue 9, 2012, Pages 892-902

  Wang, Yiping ^a   Zheng, Dong ^a   Cao, Qi ^a   Lee, Vincent W S ^a   Wang, Ya ^a   Zheng, Guoping ^a   Wang, Yuanmin ^b   Tan, Thian Kui ^a   Wang, Changqi ^a   Alexander, Stephen I ^b   Harris, David C H ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

adoptive transfer; chronic kidney disease; plasmacytoid dendritic cells

Indexed keywords

CREATININE; CYTOKINE; DOXORUBICIN; LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR FOXP3;

ADRIAMYCIN NEPHROPATHY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE CLEARANCE; CYTOKINE PRODUCTION; DRUG INDUCED DISEASE; EX VIVO STUDY; GLOMERULOSCLEROSIS; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; IMMUNOLOGICAL TOLERANCE; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TUBULE DISORDER; LYMPH NODE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEINURIA; SPLEEN;

EID: 84862786796     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.471     Document Type: Article

References (52)

1. Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004; 5: 1219-1226. (Pubitemid 41057736)
2. Nakano H, Yanagita M, Gunn MD. CD11c(f)B220(r)Gr-1(2) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J Exp Med 2001; 194: 1171-1178. (Pubitemid 32995786)
3. Salio M, Palmowski MJ, Atzberger A et al. CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens. J Exp Med 2004; 199: 567-579. (Pubitemid 38233840)
4. Steinbrink K, Wölfl M, Jonuleit H et al. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997; 159: 4772-4780. (Pubitemid 127471012)
5. Gonzalez-Rey E, Chorny A, Fernandez-Martin A et al. Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells. Blood 2006; 107: 3632-3638.
6. Ilarregui JM, Croci DO, Bianco GA et al. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat Immunol 2009; 10: 981-991.
7. Boonstra A, Asselin-Paturel C, Gilliet MC et al. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J Exp Med 2003; 197: 101-109. (Pubitemid 36110261)
8. Zuniga EI, McGavern DB, Pruneda-Paz JL et al. Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection. Nat Immunol 2004; 5: 1227-1234. (Pubitemid 41057737)
9. Ito T, Amakawa R, Inaba M et al. Plasmacytoid dendritic cells regulate Th cell responses through OX40 ligand and type I IFNs. J Immunol 2004; 172: 4253-4259. (Pubitemid 38375238)
10. Abe M, Wang Z, de Creus A et al. Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival. Am J Transplant 2005; 5: 1808-1819. (Pubitemid 41039853)
11. Zwiorek K, Bourquin C, Battiany J et al. Delivery by cationic gelatin nanoparticles strongly increases the immunostimulatory effects of CpG oligonucleotides. Pharm Res 2008; 25: 551-562. (Pubitemid 351357729)
12. Ellestad KK, Tsutsui S, Noorbakhsh F et al. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells. J Immunol 2009; 183: 298-309.
13. Mazariegos GV, Zahorchak AF, Reyes J et al. Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant 2003; 3: 689-696. (Pubitemid 36745241)
14. Waller EK, Rosenthal H, Jones TW et al. Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. Blood 2001; 97: 2948-2956.
15. Farkas L, Beiske K, Lund-Johansen F et al. Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 2001; 159: 237-243. (Pubitemid 33704208)
16. Hadeiba H, Sato T, Habtezion A et al. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat Immunol 2008; 9: 1253-1260.
17. Bailey-Bucktrout SL, Caulkins SC, Goings G et al. Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. J Immunol 2008; 180: 6457-6461.
18. Moseman EA, Liang X, Dawson AJ et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J Immunol 2004; 173: 4433-4442. (Pubitemid 39280673)
19. Mellor AL, Baban B, Chandler P et al. Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J Immunol 2003; 171: 1652-1655. (Pubitemid 36966447)
20. Munn DH, Sharma MD, Hou D et al. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest 2004; 114: 280-290. (Pubitemid 39071633)
21. Mahajan D, Wang Y, Qin X et al. CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease. J Am Soc Nephrol 2006; 17: 2731-2741. (Pubitemid 44484663)
22. Cao Q, Wang Y, Zheng D et al. IL-10/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis. J Am Soc Nephrol 2010; 21: 933-942.
23. Wang Y, Wang YP, Zheng G et al. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int 2007; 72: 290-299. (Pubitemid 47172367)
24. Kruger T, Benke D, Eitner F et al. Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J Am Soc Nephrol 2004; 15: 613-621. (Pubitemid 38294791)
25. Woltman AM, de Fijter JW, Zuidwijk K et al. Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions. Kidney Int 2007; 71: 1001-1008. (Pubitemid 46741991)
26. Tucci M, Calvani N, Richards HB et al. The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis. Ann NY Acad Sci 2005; 1051: 421-432. (Pubitemid 41362772)
27. Coates PT, Duncan FJ, Colvin BL et al. In vivo-mobilized kidney dendritic cells are functionally immature, subvert alloreactive T-cell responses, and prolong organ allograft survival. Transplantation 2004; 77: 1080-1089. (Pubitemid 38508927)
28. John R, Nelson PJ. Dendritic cells in the kidney. J Am Soc Nephrol 2007; 18: 2628-2635. (Pubitemid 47531188)
29. Scholz J, Lukacs-Kornek V, Engel DR et al. Renal dendritic cells stimulate IL-10 production and attenuate nephrotoxic nephritis. J Am Soc Nephrol 2008; 19: 527-537. (Pubitemid 351355396)
30. Tadagavadi RK, Reeves WB. Renal dendritic cells ameliorate nephrotoxic acute kidney injury. J Am Soc Nephrol 2010; 21: 53-63.
31. Kim MG, Su BC, Sook KY et al. Depletion of kidney CD11c+ F4/80+ cells impairs the recovery process in ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant 2010; 25: 2908-2921.
32. Heymann F, Meyer-Schwesinger C, Hamilton-Williams EE et al. Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest 2009; 119: 1286-1297.
33. Gao W, Demirci G, Strom TB et al. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival. Transplantation 2003; 76: 994-999. (Pubitemid 37186034)
34. Ozkaynak E, Wang L, Goodearl A et al. Programmed death-1 targeting can promote allograft survival. J Immunol 2002; 169: 6546-6553. (Pubitemid 36903507)
35. Munn DH, Mellor AL. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 2007; 117: 1147-1154. (Pubitemid 46718399)
36. Munn DH, Zhou M, Attwood JT et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998; 281: 1191-1193. (Pubitemid 28406294)
37. Fallarino F, Asselin-Paturel C, Vacca C et al. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J Immunol 2004; 173: 3748-3754. (Pubitemid 39280736)
38. Chen W, Liang X, Peterson AJ et al. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J Immunol 2008; 181: 5396-5404.
39. de Heer HJ, Hammad H, Soullie T et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 2004; 200: 89-98. (Pubitemid 38924731)
40. Arpinati M, Chirumbolo G, Urbini B et al. Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation. Transpl Immunol 2003; 11: 345-356. (Pubitemid 37120553)
41. Tokita D, Mazariegos GV, Zahorchak AF et al. High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. Transplantation 2008; 85: 369-377. (Pubitemid 351322760)
42. Castellaneta A, Sumpter TL, Chen L et al. NOD2 ligation subverts IFN-alpha production by liver plasmacytoid dendritic cells and inhibits their T cell allostimulatory activity via B7-H1 up-regulation. J Immunol 2009; 183: 6922-6932.
43. Okada T, Lian ZX, Naiki M et al. Murine thymic plasmacytoid dendritic cells. Eur J Immunol 2003; 33: 1012-1019. (Pubitemid 36546689)
44. Kahler DJ, Mellor AL. T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase. Handb Exp Pharmacol 2009; 188: 165-196.
45. Taal MW, Zandi-Nejad K, Weening B et al. Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney. Kidney Int 2000; 58: 1664-1676.
46. Liu J, Beller DI. Distinct pathways for NF-kappa B regulation are associated with aberrant macrophage IL-12 production in lupus-and diabetes-prone mouse strains. J Immunol 2003; 170: 4489-4496. (Pubitemid 36519954)
47. Ogawa D, Shikata K, Matsuda M et al. Protective effect of a novel and selective inhibitor of inducible nitric oxide synthase on experimental crescentic glomerulonephritis in WKY rats. Nephrol Dial Transplant 2002; 17: 2117-2121. (Pubitemid 35446666)
48. Boasso A, Herbeuval JP, Hardy AW et al. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 2007; 109: 3351-3359. (Pubitemid 46572523)
49. Manches O, Munn D, Fallahi A et al. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism. J Clin Invest 2008; 118: 3431-3439.
50. Cao Q, Wang L, Du F et al. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells. Cell Res 2007; 17: 627-637. (Pubitemid 47116358)
51. Blumenthal R, Sarkar DP, Durell S et al. Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events. J Cell Biol 1996; 135: 63-71. (Pubitemid 26337737)
52. Rangan GK, Tesch GH. Quantification of renal pathology by image analysis. Nephrology (Carlton) 2007; 12: 553-558.